Cerebral blood flow and oxygen metabolism measured with the Kety-Schmidt method using nitrous oxide
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Cerebral blood flow and oxygen metabolism measured with the Kety-Schmidt method using nitrous oxide. / Taudorf, S; Berg, R M G; Bailey, D M; Møller, K.
I: Acta Anaesthesiologica Scandinavica Supplementum, Bind 53, Nr. 2, 02.2009, s. 159-67.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cerebral blood flow and oxygen metabolism measured with the Kety-Schmidt method using nitrous oxide
AU - Taudorf, S
AU - Berg, R M G
AU - Bailey, D M
AU - Møller, K
PY - 2009/2
Y1 - 2009/2
N2 - BACKGROUND: The Kety-Schmidt method is the reference method for measuring global cerebral blood flow (CBF), cerebral metabolic rates (CMR) and flux, especially where scanners are unavailable or impractical. Our primary objective was to assess the repeatability of the Kety-Schmidt method in a variety of different approaches using inhaled nitrous oxide (N2O) as the tracer, combined with photoacoustic spectrometry. A secondary objective was to assess the impact of this tracer on the systemic vascular concentration of nitrite (NO2(-)).METHODS: Twenty-nine healthy male volunteers underwent 61 CBF measurements by breathing a normoxic gas mixture containing 5% N2O until tension equilibrium. Paired blood samples were collected from an arterial and a jugular bulb catheter in the saturation or desaturation phase, by continuous or the discontinuous sampling. N2O concentration was measured with photoacoustic spectrometry after equilibration of blood samples with air. CBF was calculated by the Kety-Schmidt equation. CMR of oxygen (CMRO2) was determined by the Fick principle. NO2(-) in plasma and red blood cells (RBC) was measured by ozone-based chemiluminescence.RESULTS: The most robust approach for CBF measurement was achieved by discontinuous sampling in the desaturation phase [CBF, 64 (95% confidence interval, 59-71 ml)] 100 g/min; CMRO2 1.8 (1.7-2.0) micromol/g/min). The tracer did not influence plasma or RBC NO2(-) (P>0.05 vs. baseline).CONCLUSION: These findings confirm the reliability and robustness of the Kety-Schmidt method using inhaled N2O for the measurement of global CBF and CMR. At the low tracer concentration used, altered NO metabolism is unlikely to have affected cerebral haemodynamic function.
AB - BACKGROUND: The Kety-Schmidt method is the reference method for measuring global cerebral blood flow (CBF), cerebral metabolic rates (CMR) and flux, especially where scanners are unavailable or impractical. Our primary objective was to assess the repeatability of the Kety-Schmidt method in a variety of different approaches using inhaled nitrous oxide (N2O) as the tracer, combined with photoacoustic spectrometry. A secondary objective was to assess the impact of this tracer on the systemic vascular concentration of nitrite (NO2(-)).METHODS: Twenty-nine healthy male volunteers underwent 61 CBF measurements by breathing a normoxic gas mixture containing 5% N2O until tension equilibrium. Paired blood samples were collected from an arterial and a jugular bulb catheter in the saturation or desaturation phase, by continuous or the discontinuous sampling. N2O concentration was measured with photoacoustic spectrometry after equilibration of blood samples with air. CBF was calculated by the Kety-Schmidt equation. CMR of oxygen (CMRO2) was determined by the Fick principle. NO2(-) in plasma and red blood cells (RBC) was measured by ozone-based chemiluminescence.RESULTS: The most robust approach for CBF measurement was achieved by discontinuous sampling in the desaturation phase [CBF, 64 (95% confidence interval, 59-71 ml)] 100 g/min; CMRO2 1.8 (1.7-2.0) micromol/g/min). The tracer did not influence plasma or RBC NO2(-) (P>0.05 vs. baseline).CONCLUSION: These findings confirm the reliability and robustness of the Kety-Schmidt method using inhaled N2O for the measurement of global CBF and CMR. At the low tracer concentration used, altered NO metabolism is unlikely to have affected cerebral haemodynamic function.
KW - Adult
KW - Algorithms
KW - Blood-Brain Barrier
KW - Brain/metabolism
KW - Carbon Dioxide/blood
KW - Cerebrovascular Circulation
KW - Erythrocytes/chemistry
KW - Hematocrit
KW - Humans
KW - Hydrogen-Ion Concentration
KW - Hypocapnia/blood
KW - Male
KW - Nitric Oxide/metabolism
KW - Nitrites/blood
KW - Nitrous Oxide/pharmacokinetics
KW - Oxygen/blood
KW - Oxygen Consumption
KW - Partial Pressure
KW - Plasma/chemistry
KW - Reproducibility of Results
KW - Spectrum Analysis/methods
KW - Young Adult
U2 - 10.1111/j.1399-6576.2008.01788.x
DO - 10.1111/j.1399-6576.2008.01788.x
M3 - Journal article
C2 - 19076112
VL - 53
SP - 159
EP - 167
JO - Acta Anaesthesiologica Scandinavica
JF - Acta Anaesthesiologica Scandinavica
SN - 0001-5172
IS - 2
ER -
ID: 237006547